Hypereosinophile Syndrome

Translated title of the contribution: Hypereosinophilic syndrome

F. Moosig*, G. Richardt, C. Merten, W. L. Gross

*Corresponding author for this work
5 Citations (Scopus)


Hypereosinophilic syndrome is a heterogeneous group of diseases characterized by blood hypereosinophilia and eosinophil-related organ damage. A comprehensive diagnostic work-up is necessary to identify underlying conditions and to detect organ involvement, which are important for prognosis. Involvement of the heart is related with a poorer outcome. Some underlying conditions can be treated with targeted therapies, e.g., tyrosine kinase inhibitors. However, glucocorticoids in combination with steroid-sparing drugs are generally used for treatment. Furthermore, the growing understanding of the molecular pathogenesis will lead to new therapies, e.g., the use of anti-cytokine antibodies.

Translated title of the contributionHypereosinophilic syndrome
Original languageGerman
Issue number4
Pages (from-to)426-433
Number of pages8
Publication statusPublished - 04.2013

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)


Dive into the research topics of 'Hypereosinophilic syndrome'. Together they form a unique fingerprint.

Cite this